While previous studies have shown the anti-inflammatory properties of morin in various diseases [18,50,51], our findings are the first to demonstrate its inhibitory effects on the NLRP3 inflammasome in NSCLC, highlighting its potential as a novel anti-cancer agent. The gene discussed is NLRP3; the disease is non-small cell lung carcinoma.